Advertisement
Screener

SI-BONE, INC. (SIBN) Graph

SIBN Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $56.01M; Cost of revenue $11.46M; Research and development $5.22M; Operating expenses $49.35M.
  • 2026-03-31: Revenue $52.59M; Cost of revenue $10.64M; Research and development $4.19M; Operating expenses $47.04M.
  • 2025-12-31: Revenue $56.35M*; Cost of revenue $11.82M*; Research and development $4.36M*; Operating expenses $46.99M*.
  • 2025-09-30: Revenue $48.66M; Cost of revenue $9.81M; Research and development $4.24M; Operating expenses $44.23M.

Geography

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

SIBN revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Non Us$2.78MUS$53.23MRevenue$56.01MCost of revenue$11.46MGross profit$44.55MOperating expenses$49.35MOperating income-$4.81MOther income, net-$16.00KResearch & development$5.22MIncome tax$0.00Net income-$4.09M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$56.01M$11.46M$5.22M$49.35M$0.00-$4.09M
2026-03-31$52.59M$10.64M$4.19M$47.04M$0.00-$4.33M
2025-12-31$56.35M*$11.82M*$4.36M*$46.99M*$0.00*-$1.64M*
2025-09-30$48.66M$9.81M$4.24M$44.23M$0.00-$4.57M
2025-06-30$48.63M$9.82M$4.31M$45.81M$0.00-$6.15M
2025-03-31$47.29M$9.60M$4.53M$45.17M$0.00-$6.54M
2024-09-30$40.34M$8.44M$3.99M$39.54M$0.00-$6.58M
2024-06-30$39.97M$8.39M$4.35M$41.65M$0.00-$8.94M
2024-03-31$37.87M$8.00M$4.34M$41.91M$0.00-$10.90M
2023-09-30$34.01M$7.04M$3.92M$38.14M$0.00-$10.02M
2023-06-30$33.30M$6.32M$3.66M$38.95M$0.00-$11.21M
2023-03-31$32.71M$5.92M$3.29M$38.08M$0.00-$11.13M
2022-09-30$26.43M$4.17M$3.09M$35.83M$0.00-$14.16M
2022-06-30$25.59M$3.46M$3.48M$40.00M$0.00-$18.51M
2022-03-31$22.44M$2.98M$3.58M$36.32M$0.00-$17.41M
2021-09-30$22.29M$2.48M$3.29M$33.01M$0.00-$15.87M
2021-06-30$22.19M$2.38M$3.15M$32.78M(m)-$13.98M
2021-03-31$20.44M$2.20M$2.96M$29.82M(m)-$12.24M
2020-09-30$20.37M$2.58M$2.78M$26.47M(m)-$9.47M
2020-06-30$14.05M$2.12M$2.17M$22.07M(m)-$12.47M
2020-03-31$16.82M$1.93M$2.09M$26.77M(m)-$12.77M
2019-09-30$16.18M$1.63M$1.87M$25.13M(m)-$11.31M
2019-06-30$16.32M$1.59M$1.95M$22.87M(m)-$8.65M
2019-03-31$14.99M$1.53M$1.68M$22.26M(m)-$9.35M
2018-09-30$13.38M$1.22M$1.37M$15.20M(m)-$4.79M
2018-06-30$13.66M$1.18M$1.30M$14.18M(m)-$3.15M
2018-03-31$12.71M$1.05M$1.21M$14.58M(m)-$4.20M
2017-09-30$11.68M$1.33M$1.47M$15.39M(m)-$5.68M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$108.60M$22.11M$9.41M$96.39M$0.00-$8.42M
2025-06-30$95.92M$19.42M$8.84M$90.99M$0.00-$12.69M
2024-06-30$77.84M$16.39M$8.70M$83.56M$0.00-$19.84M
2023-06-30$66.01M$12.24M$6.95M$77.03M$0.00-$22.33M
2022-06-30$48.02M$6.45M$7.06M$76.33M$0.00-$35.92M
2021-06-30$42.64M$4.58M$6.10M$62.60M(m)-$26.22M
2020-06-30$30.87M$4.05M$4.25M$48.84M(m)-$25.24M
2019-06-30$31.31M$3.11M$3.63M$45.13M(m)-$18.00M
2018-06-30$26.38M$2.23M$2.50M$28.76M(m)-$7.35M

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$144.58M$29.23M$13.09M$135.22M$0.00-$17.26M
2024-09-30$118.18M$24.83M$12.69M$123.10M$0.00-$26.42M
2023-09-30$100.03M$19.28M$10.87M$115.17M$0.00-$32.35M
2022-09-30$74.46M$10.62M$10.15M$112.16M$0.00-$50.08M
2021-09-30$64.92M$7.05M$9.39M$95.61M$0.00-$42.09M
2020-09-30$51.24M$6.63M$7.03M$75.31M(m)-$34.72M
2019-09-30$47.49M$4.74M$5.50M$70.26M(m)-$29.30M
2018-09-30$39.76M$3.45M$3.88M$43.96M(m)-$12.14M
2017-09-30$34.21M$3.89M$4.23M$46.03M(m)-$18.13M

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$200.93M$41.05M$17.45M$182.21M$0.00-$18.90M
2024-12-31$167.18M$35.06M$16.56M$167.37M$0.00-$30.90M
2023-12-31$138.89M$29.47M$15.03M$156.35M$0.00-$43.30M
2022-12-31$106.41M$15.71M$13.63M$150.31M$0.00-$61.30M
2021-12-31$90.15M$10.43M$12.44M$131.39M$0.00-$56.60M
2020-12-31$73.39M$8.90M$9.46M$103.05M(m)-$43.70M
2019-12-31$67.30M$6.79M$7.28M$96.51M(m)-$38.40M
2018-12-31$55.38M$4.83M$5.38M$62.51M$0.00-$17.45M
2017-12-31$47.98M$5.11M$5.51M$60.22M$0.00-$23.04M

Similar stocks

Stock NameCountryMarket CapPE Ratio
SpyGlass Pharma, Inc. (SGP)United States$0.925B
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
ANGIODYNAMICS INC (ANGO)United States$0.632B-13.02
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
ORTHOPEDIATRICS CORP (KIDS)United States$0.592B
SS Innovations International, Inc. (SSII)$0.589B-64.06
IRADIMED CORP (IRMD)United States$1.089B52.92
DELCATH SYSTEMS, INC. (DCTH)United States$0.558B820.33